牛隻保健市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按治療和診斷、按地區、競爭細分

2022 年，全球牛隻健康市場估值達到 80.1 億美元，預計在預測期內將出現令人印象深刻的成長，預計到 2028 年年複合成長率 (CAGR) 為 7.48%。牛隻健康涵蓋了整體牛、主要用於肉類生產（肉牛）、產奶（乳牛）、工作甚至寵物等目的的馴養反芻動物的健康和身體狀況。維持牛的健康對於它們的福利、生產力以及安全優質動物產品的生產至關重要。牛隻健康管理的一個基本面向涉及疾病預防，透過疫苗接種計劃、生物安全措施和旨在減輕可能影響牛隻的傳染病風險的牛群健康計劃來實現。疾病的早​​期發現和診斷對於及時治療和控制至關重要，獸醫採用各種診斷工具，包括血液檢查、糞便檢查和身體檢查。

全球人口的成長和人均收入水準的提高導致對肉類，特別是牛肉的需求不斷成長。這種需求的增加強調了維持牛群健康和生產力的必要性，從而刺激了對牛隻健康管理的投資。牛群內疾病的爆發可能會對養牛者造成嚴重的經濟後果。因此，疫苗接種和疾病管理策略等預防性醫療措施對於最大限度地減少損失、推動對牛隻保健產品和服務的需求至關重要。

獸醫學和診斷技術的進步極大地改善了牛的疾病檢測、治療和管理。這些技術創新提高了牛隻健康解決方案的有效性並吸引了更多投資。許多政府和監管機構已將重點轉向動物健康和福利，並可能實施促進疾病預防和負責任的牛隻健康管理實踐的計劃和法規。此外，消費者對肉製品的安全性和永續性越來越關注。因此，養牛生產者有動力投資牛的健康，以確保生產符合消費者需求的安全、優質牛肉產品。

市場概況
預測期	2024-2028
2022 年市場規模	80.1億美元
2028 年市場規模	123.7億美元
2023-2028 年年複合成長率	7.48%
成長最快的細分市場	疫苗
最大的市場	北美洲

主要市場促進因素

技術進步

穿戴式裝置和感測器擴大用於監測牛的健康狀況。這些設備可以追蹤體溫、心率和活動水平等生命徵象，使農民和獸醫能夠發現疾病的早期跡象。數據分析和大資料技術應用於養牛場產生的大量資料。透過分析這些資料，農民可以就牛的健康和管理做出更明智的決策。無人機和衛星影像用於遠端監控牧場和牛群。這項技術可以識別過度放牧或掠食者的存在等問題，有助於改善牛群健康。精準畜牧業涉及利用技術根據個別動物或群體的具體需求客製化管理實踐。這可以包括精確的餵食方式、藥物劑量和環境控制。區塊鏈技術用於追蹤牛從出生到加工的整個生命週期。這確保了透明度和可追溯性，這對於食品安全和品質保證非常重要。基因組定序和基因測試用於鑑定具有理想性狀的牛，例如抗病性、改善的肉質和更高的產奶量。這項技術為育種決策提供資訊。

對人畜共通傳染病的擔憂日益增加

人畜共通傳染病，如布氏桿菌病、Q 熱和大腸桿菌 O157:H7，可能對人類造成嚴重的健康風險。控制牛隻的這些疾病有助於減少人類感染的可能性，保護公眾健康。人畜共通病原體會污染牛隻產品，包括牛肉和乳製品。透過疾病預防和監測計劃確保牛的健康對於生產安全、無病原體的肉類和乳製品至關重要。 「同一個健康」概念認知到人類、動物和環境健康的相互關聯性。解決牛的人畜共通傳染病符合這種整體方法，強調需要協調一致的努力來保護人類和動物的健康。許多國家製定了預防牛人畜共通傳染病的法規和標準。遵守這些法規對於國際貿易和維持市場准入至關重要。消費者越來越關注食品安全及其食品的來源。強而有力的牛隻健康管理計畫可以最大限度地降低人畜共患疾病的風險，有助於維持消費者對牛肉和乳製品的信心。

快速檢測和控制牛中人畜共通傳染病的爆發對於預防牛群和人類之間的大規模流行病至關重要。透過常規健康監測可以進行早期介入。疫苗是預防牛隻的人畜共通傳染病（如布魯氏菌病）的重要工具。實施有效的疫苗接種計畫是減少人畜共通傳染病傳播的關鍵策略。農民和養牛戶接受有關人畜共通傳染病風險和預防措施的教育和培訓。這些知識使他們能夠實施牛隻健康管理的最佳實踐。正在進行的研究和疾病監測工作重點關注牛的人畜共通病原體。監測這些病原體的流行和分佈有助於識別新出現的威脅並為預防策略提供資訊。在全球化的世界中，人畜共通傳染病可以迅速跨越國界。從源頭（包括牛群）預防這些疾病是全球衛生安全工作的一部分。人畜共通傳染病的擔憂可能會導致養牛業中抗生素使用的減少。這對於減輕抗生素抗藥性非常重要，抗生素抗藥性是全球健康威脅。這項因素將加速全球牛隻健康市場的需求

增加畜群規模

較大的牛群較難以單獨監測。隨著畜群規模的增加，更加需要先進的監測技術和系統，例如數位健康監測和感測器，以追蹤每隻動物的健康和福祉。在較大的牛群中，疾病爆發的風險和疾病快速傳播的可能性可能更高。為了預防和控制疾病，對診斷測試和監測系統等早期疾病檢測工具的需求不斷增加。向較大的牛群注射疫苗和藥物可能是後勤方面的挑戰。牛的健康管理計劃必須有效率且組織良好，以確保所有動物都接受必要的疫苗接種和治療。這推動了對高效輸送系統和藥品的需求。較大的牛群通常更容易受到外部來源疾病的影響。實施生物安全措施，例如控制農場進入和新動物檢疫協議，對於防止疾病傳播至關重要。管理更大的牛群可能需要更多的勞動力。高效的牛隻健康管理實踐和技術採用對於最佳化勞動力資源和最大限度地降低營運成本至關重要。

對於較大的牛群，制定全面的牛群健康管理計畫變得至關重要。這些計劃概述了整個牛群的疫苗接種時間表、疾病預防策略和治療方案。管理大群中個體動物的相關資料可能具有挑戰性。數位記錄保存系統和資料分析工具成為有效追蹤和管理牛隻健康資訊的必要條件。獸醫在管理大群牛的健康方面發揮關鍵作用。對獸醫服務的需求，包括牛群健康評估和疾病控制策略，隨著牛群規模的增加而增加。疫苗接種和營養管理等預防性醫療措施對於維持較大牛群的健康和生產力至關重要。更加重視疾病預防，以避免重大生產損失。較大牛群的疾病爆發或健康問題可能會產生巨大的經濟影響。牛生產者有強烈的動機投資於牛的健康管理，以保護其投資並確保盈利。隨著畜群規模的擴大，可追溯性對於食品安全和品質保證變得越來越重要。強大的記錄保存系統對於追蹤個體動物的歷史和健康狀況是必要的。較大的牛群可能需要更多的資源，例如飼料和水。實施永續的牛隻健康管理實踐，例如有效的資源利用和廢棄物管理，對於最大限度地減少環境影響至關重要。這項因素將加速全球牛隻保健市場的需求

主要市場挑戰

疾病爆發

疾病爆發可能對養牛者造成巨大的經濟損失。這些損失的發生可能是由於生產力下降、獸醫和治療成本增加，甚至為了控制疾病傳播而撲殺受感染的動物。受疾病影響的牛隻可能會出現生長速度下降、產奶量降低（乳牛）和繁殖性能下降的情況。這些因素可能導致牛群整體生產力和獲利能力下降。治療受感染的牛隻可能成本高昂。患病動物對藥物、獸醫護理和隔離設施的需求可能會導致養牛生產者的財政資源緊張。疾病爆發可能導致牛和牛產品在國內和國際上暫時或永久失去市場准入。進口國可能會限制或禁止從受疾病爆發影響的地區進口牛和牛肉。疾病爆發可能會擾亂牛和牛產品的全球貿易。出口限制、檢疫措施和貿易爭端可能會影響市場動態和價格。牛的疾病爆發可能會削弱消費者對牛肉和乳製品安全和品質的信心。這可能導致需求減少和市場不確定性。為了應對疾病爆發，政府可能會加強對牛隻健康的監管和監測。這可能會為養牛生產者帶來額外的合規成本和文書工作。疾病爆發凸顯了養牛場生物安全措施的重要性。養牛生產者可以投資改善生物安全措施，以防止未來的疫情爆發。

抗生素抗藥性

牛體內的抗生素抗藥性感染會限制常用於疾病治療的抗生素的有效性。這意味著某些疾病的管理和治療變得更具挑戰性，導致發病率和死亡率增加。使用抗生素作為最後手段或抗生素抗藥性感染的替代療法可能會更昂貴。這給養牛者帶來了經濟負擔，他們可能需要在醫療保健和疾病管理方面進行更多投資。牛的抗生素抗藥性可能導致抗藥性病原體的產生和傳播。如果這些病原體進入食品供應或環境，可能會造成重大的公共衛生風險，因為抗生素抗藥性細菌可能會感染人類。為了應對抗生素抗藥性的擔憂，監管機構可能會限制在養牛業中使用某些抗生素。這可能會影響治療方案，並要求養牛生產者採取替代醫療保健策略。消費者越來越關注畜牧業中抗生素的使用。他們可能會尋求標有不含抗生素或採用負責任的抗生素使用實踐生產的牛肉和乳製品。滿足這些消費者偏好可能需要改變牛隻的健康管理。有些國家對養牛業抗生素的使用有具體規定，遵守這些規定對國際貿易是必要的。抗生素抗藥性問題可能會影響市場准入和貿易談判。對抗生素抗藥性的擔憂導致牛隻健康市場轉向替代醫療保健策略。這包括開發和採用疫苗、益生菌、益生元和其他基於非抗生素的疾病預防和管理解決方案。獸醫在管理牛隻健康中抗生素的使用方面發揮關鍵作用。獸醫可能會加強審查和監督，以確保負責任地使用抗生素並遵守監管指南。

主要市場趨勢

可追溯性和食品安全

消費者越來越關注他們所消費的食品的安全和質量，包括牛肉和乳製品。可追溯系統和食品安全措施為消費者提供透明度和保證，增強他們對這些產品的信心。許多消費者尋求標有肉類或乳製品原產地資訊的產品，包括有關牛隻的飼養地點和方式的詳細資訊。此標籤提供一定程度的可追溯性，幫助消費者做出明智的選擇。許多國家的監管機構對養牛業的可追溯性和食品安全實施了嚴格的要求。遵守這些法規對於養牛生產者合法經營和進入市場至關重要。如果發生食品安全問題或產品召回，追溯系統可以快速識別受影響的產品和污染源。這有助於最大限度地減少召回的範圍和影響。可追溯系統可以幫助疾病監測和應對工作。如果疾病爆發，當局可以追蹤牛隻的活動，以確定潛在的感染源並更有效地實施控制措施。可追溯系統提供了從農場到餐桌的整個牛供應鏈的透明度。這種透明度有助於識別和解決供應鏈中潛在的瓶頸或低效率。透過強力的健康管理實踐確保牛隻的健康和福祉是食品安全和品質保證的一個基本面向。健康的牛攜帶人畜共通傳染病或污染肉類和乳製品的病原體的可能性較小。基因追蹤變得越來越普遍，消費者可以追蹤牛的基因遺產。這可用於驗證品種真實性並確保產品品質。一些追溯系統使用區塊鏈技術來創建與牛相關的資料的不可變記錄。區塊鏈保證了資料的完整性和安全性，使得資訊難以被篡改或更改。

細分市場洞察

治療見解

2022年，全球牛隻健康市場在預測期內以疫苗領域為主，預計未來幾年將繼續擴大。疫苗是養牛業預防性醫療保健的基石。它們對於保護牛免受多種疾病（包括病毒和細菌感染）至關重要。疫苗接種有助於減少疾病的發生率和嚴重程度，降低死亡率和生產損失。牛隻容易感染多種疾病，包括牛呼吸道疾病、布魯氏菌病、牛病毒性腹瀉和口蹄疫等。疫苗部門提供多種旨在預防或控制這些疾病的疫苗，使其成為牛隻健康管理的重要組成部分。在一些地區，疫苗接種在疾病根除計畫中發揮關鍵作用。例如，疫苗接種用於控制並最終消除特定地理區域的口蹄疫等疾病。

診斷見解

2022 年，全球牛隻健康市場將由免疫診斷測試領域主導，預計未來幾年將繼續擴大。免疫診斷測試，例如酵素連結免疫吸附測定 (ELISA) 和快速診斷測試，對於檢測牛隻的各種疾病非常有效。這些測試可以檢測與疾病相關的特定抗體或抗原，從而實現早期、準確的診斷。養牛者和獸醫經常使用免疫診斷測試作為其預防性醫療計劃的一部分。定期檢測有助於在疾病的早期階段發現疾病，從而能夠及時治療並防止疾病在牛群內爆發。大型養牛場，包括飼養場和乳牛場，依靠免疫診斷測試來有效管理牛群的健康。定期測試有助於監測牛群的整體健康狀況並發現任何潛在問題。

區域洞察

到 2022 年，北美地區將主導全球牛隻健康市場。北美，特別是美國和加拿大，擁有大量牛群。美國是世界上最大的牛肉生產國之一。如此龐大的牛群為牛隻健康產品和服務創造了巨大的市場。北美擁有完善且先進的獸醫護理系統。這包括許多熟練的獸醫、現代獸醫診所和專注於牛隻健康的研究機構。這些資源有助於創新牛隻健康解決方案的開發和採用。北美一直處於採用先進農業技術（包括養牛業）的前沿。該地區採用了數位健康監測、資料分析和精準畜牧業，從而增強了牛隻的健康管理。

目錄

第 1 章：產品概述

• 市場定義
• 市場範圍
  • 涵蓋的市場
  • 研究年份
  • 主要市場區隔

第 2 章：研究方法

• 研究目的
• 基線方法
• 主要產業夥伴
• 主要協會和二手資料來源
• 預測方法
• 數據三角測量與驗證
• 假設和限制

第 3 章：執行摘要

• 市場概況
• 主要市場細分概述
• 主要市場參與者概述
• 重點地區/國家概況
• 市場促進因素、挑戰、趨勢概述

第 4 章：COVID-19 對全球牛隻健康市場的影響

第 5 章：客戶之聲

第 6 章：全球牛隻健康市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依治療藥物（疫苗、殺寄生蟲劑、抗感染藥、醫用飼料添加劑和其他治療藥物）
  • 按診斷（免疫診斷測試、分子診斷、診斷影像、臨床化學和其他診斷）
  • 按地區
  • 按公司分類 (2022)
• 市場地圖

第 7 章：亞太地區牛隻保健市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 透過治療學
  • 透過診斷
  • 按國家/地區
• 亞太地區：國家分析
  • 中國牛健康
  • 印度牛健康
  • 澳洲牛健康
  • 日本牛健康
  • 韓國牛健康

第 8 章：歐洲牛保健市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 透過治療學
  • 透過診斷
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 9 章：北美牛隻保健市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 透過治療學
  • 透過診斷
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 10 章：南美洲牛保健市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 透過治療學
  • 透過診斷
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 11 章：中東和非洲牛保健市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 透過治療學
  • 透過診斷
  • 按國家/地區
• MEA：國家分析
  • 南非 牛健康
  • 沙烏地阿拉伯牛健康
  • 阿拉伯聯合大公國牛健康

第 12 章：市場動態

• 促進要素
• 挑戰

第 13 章：市場趨勢與發展

• 最近的發展
• 產品發布
• 併購

第 14 章：全球牛隻健康市場：SWOT 分析

第 15 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第 16 章：大環境分析

第17章：競爭格局

• 商業概覽
• 公司概況
• 產品與服務
• 財務（上市公司）
• 最近的發展
• SWOT分析
  • Qiagen LLC
  • Boehringer Ingelheim
  • Thermo Fisher Scientific
  • Elanco Animal Health
  • Idexx Laboratories
  • ID Vet
  • Kyoritsuseiyaku Corporation
  • Merck & Co Inc.
  • Norbrook laboratories
  • Zoetis Inc.

第 18 章：策略建議

第 19 章：關於我們與免責聲明

In 2022, the Global Cattle Health Market achieved a valuation of USD 8.01 billion, and it is poised to witness impressive growth in the forecasted period, with a projected Compound Annual Growth Rate (CAGR) of 7.48% through 2028. Cattle health encompasses the overall well-being and physical condition of cattle, domesticated ruminant animals primarily raised for purposes such as meat production (beef cattle), milk production (dairy cattle), work, or even as pets. Maintaining the health of cattle is paramount for their welfare, productivity, and the production of safe and high-quality animal products. A fundamental aspect of cattle health management involves disease prevention, achieved through vaccination programs, biosecurity measures, and herd health plans aimed at mitigating the risk of infectious diseases that can impact cattle. The early detection and diagnosis of diseases are critical for timely treatment and control, and veterinarians employ various diagnostic tools, including blood tests, fecal examinations, and physical examinations.

The increasing global population and rising per capita income levels have led to a growing demand for meat, particularly beef. This heightened demand underscores the necessity for maintaining healthy and productive cattle herds, thereby stimulating investments in cattle health management. Disease outbreaks within cattle herds can result in severe economic consequences for cattle producers. As a result, preventive healthcare measures like vaccination and disease management strategies are imperative for minimizing losses, driving the demand for cattle health products and services.

Advancements in veterinary medicine and diagnostic technologies have substantially improved disease detection, treatment, and management in cattle. These technological innovations enhance the effectiveness of cattle health solutions and attract increased investment. Many governments and regulatory bodies have shifted their focus towards animal health and welfare and may implement programs and regulations that promote disease prevention and responsible cattle health management practices. Additionally, consumers are displaying growing concern about the safety and sustainability of meat products. Consequently, cattle producers are incentivized to invest in cattle health to ensure the production of safe, high-quality beef products that align with consumer demands.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 8.01 Billion
Market Size 2028	USD 12.37 Billion
CAGR 2023-2028	7.48%
Fastest Growing Segment	Vaccine
Largest Market	North America

Key Market Drivers

Technological Advancements

Wearable devices and sensors are increasingly used to monitor cattle health. These devices can track vital signs, such as temperature, heart rate, and activity levels, allowing farmers and veterinarians to detect early signs of illness. Data analytics and big data techniques are applied to the vast amounts of data generated on cattle farms. By analyzing this data, farmers can make more informed decisions regarding cattle health and management. Drones and satellite imagery are used for remote monitoring of pastures and cattle herds. This technology can identify issues like overgrazing or the presence of predators, helping improve herd health. Precision livestock farming involves using technology to tailor management practices to individual animals or groups based on their specific needs. This can include precise feeding regimes, medication dosages, and environmental controls. Blockchain technology is used to track the entire lifecycle of cattle, from birth to processing. This ensures transparency and traceability, which can be important for food safety and quality assurance. Genomic sequencing and genetic testing are used to identify cattle with desirable traits, such as disease resistance, improved meat quality, and higher milk production. This technology informs breeding decisions.

Advanced diagnostic tools, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISAs), allow for rapid and accurate detection of diseases in cattle. These tests can identify specific pathogens or antibodies. Telemedicine platforms enable cattle farmers and veterinarians to consult with experts remotely. This is especially valuable in rural or remote areas where access to veterinary care may be limited. In dairy farming, robotic milking systems have become more common. These systems automatically milk cows and can also monitor cow health by analyzing milk composition and production rates. Advances in biotechnology have led to the development of biopharmaceuticals, such as recombinant vaccines and genetic modification techniques. These innovations have improved disease prevention and treatment in cattle. AI is used for predictive modeling in cattle health. Machine learning algorithms can analyze historical data to predict disease outbreaks, optimize feeding programs, and improve overall herd management. Technology has enabled precise nutritional monitoring of cattle. Smart feeders and sensors can ensure that cattle receive the correct nutrients, leading to better overall health and productivity. Water quality is essential for cattle health. Sensors can monitor water sources for contaminants and ensure that cattle have access to clean and safe drinking water. This factor will help in the development of Global Cattle Health Market.

Growing Zoonotic Disease Concerns

Zoonotic diseases, such as brucellosis, Q fever, and E. coli O157:H7, can pose serious health risks to humans. Controlling these diseases in cattle helps reduce the potential for human infections, protecting public health. Zoonotic pathogens can contaminate cattle products, including beef and dairy. Ensuring the health of cattle through disease prevention and monitoring programs is critical for producing safe and pathogen-free meat and dairy products. The "One Health" concept recognizes the interconnectedness of human, animal, and environmental health. Addressing zoonotic diseases in cattle aligns with this holistic approach, emphasizing the need for coordinated efforts to protect both human and animal health. Many countries have regulations and standards in place to prevent zoonotic diseases in cattle. Compliance with these regulations is essential for international trade and maintaining market access. Consumers are increasingly concerned about food safety and the origin of their food products. A robust cattle health management program that minimizes the risk of zoonotic diseases helps maintain consumer confidence in beef and dairy products.

Rapid detection and control of zoonotic disease outbreaks in cattle are crucial for preventing larger-scale epidemics among both cattle populations and humans. Early intervention is possible through routine health monitoring. Vaccines are essential tools for preventing zoonotic diseases in cattle, such as brucellosis. Implementing effective vaccination programs is a key strategy for reducing zoonotic disease transmission. Farmers and cattle producers receive education and training on zoonotic disease risks and prevention measures. This knowledge empowers them to implement best practices for cattle health management. Ongoing research and disease surveillance efforts focus on zoonotic pathogens in cattle. Monitoring the prevalence and distribution of these pathogens helps identify emerging threats and informs prevention strategies. In a globalized world, zoonotic diseases can quickly cross borders. Preventing these diseases at their source, including in cattle populations, is a component of global health security efforts. Zoonotic disease concerns can lead to a reduction in antibiotic use in cattle farming. This is important for mitigating antibiotic resistance, which is a global health threat. This factor will pace up the demand of Global Cattle Health Market

Increasing Herd Sizes

Larger herds are more challenging to monitor individually. As herd sizes increase, there is a greater need for advanced monitoring technologies and systems, such as digital health monitoring and sensors, to keep track of the health and well-being of each animal. In larger herds, the risk of disease outbreaks and the potential for rapid disease transmission can be higher. To prevent and control diseases, there is a heightened demand for early disease detection tools, such as diagnostic tests and surveillance systems. Administering vaccines and medications to larger herds can be a logistical challenge. Cattle health management programs must be efficient and well-organized to ensure that all animals receive necessary vaccinations and treatments. This drives the demand for efficient delivery systems and pharmaceuticals. Larger herds are often more vulnerable to disease introduction from external sources. Implementing biosecurity measures, such as controlled access to the farm and quarantine protocols for new animals, becomes essential to prevent disease spread. Managing larger herds can require a larger workforce. Efficient cattle health management practices and technology adoption are essential to optimize labor resources and minimize operational costs.

With larger herds, it becomes crucial to have comprehensive herd health management plans in place. These plans outline vaccination schedules, disease prevention strategies, and treatment protocols for the entire herd. Managing data related to individual animals within a large herd can be challenging. Digital record-keeping systems and data analytics tools become necessary to track and manage cattle health information effectively. Veterinarians play a critical role in managing cattle health in large herds. The demand for veterinary services, including herd health assessments and disease control strategies, increases with herd size. Preventive healthcare measures, such as vaccination and nutrition management, are essential to maintain the health and productivity of larger herds. There is a greater emphasis on disease prevention to avoid significant production losses. The economic impact of disease outbreaks or health issues in larger herds can be substantial. Cattle producers have a strong incentive to invest in cattle health management to protect their investments and ensure profitability. As the size of the herd grows, traceability becomes increasingly important for food safety and quality assurance. Robust record-keeping systems are necessary to track the history and health status of individual animals. Larger herds may require more resources, such as feed and water. Implementing sustainable cattle health management practices, such as efficient resource utilization and waste management, is essential to minimize environmental impact. This factor will accelerate the demand of Global Cattle Health Market

Key Market Challenges

Disease Outbreaks

Disease outbreaks can result in substantial economic losses for cattle producers. These losses can occur due to reduced productivity, increased veterinary and treatment costs, and even the culling of infected animals to control the spread of the disease. Cattle affected by diseases may experience decreased growth rates, lower milk production (in dairy cattle), and reduced reproductive performance. These factors can lead to decreased overall herd productivity and profitability. Treating infected cattle can be costly. The need for medications, veterinary care, and isolation facilities for sick animals can strain the financial resources of cattle producers. Disease outbreaks can result in the temporary or permanent loss of market access for cattle and cattle products, both domestically and internationally. Importing countries may impose restrictions or bans on cattle and beef imports from regions affected by disease outbreaks. Disease outbreaks can disrupt global trade in cattle and cattle products. Export restrictions, quarantine measures, and trade disputes can impact market dynamics and prices. Disease outbreaks in cattle can erode consumer confidence in the safety and quality of beef and dairy products. This can lead to decreased demand and market uncertainty. In response to disease outbreaks, governments may increase regulatory oversight and surveillance of cattle health. This can result in additional compliance costs and paperwork for cattle producers. Disease outbreaks highlight the importance of biosecurity practices on cattle farms. Cattle producers may invest in improved biosecurity measures to prevent future outbreaks.

Antibiotic Resistance

Antibiotic-resistant infections in cattle can limit the effectiveness of antibiotics commonly used for disease treatment. This means that some diseases become more challenging to manage and treat, leading to increased morbidity and mortality rates. The use of antibiotics of last resort or alternative treatments for antibiotic-resistant infections could be more expensive. This places financial burdens on cattle producers, who may need to invest more in healthcare and disease management. Antibiotic resistance in cattle can lead to the development and spread of drug-resistant pathogens. If these pathogens enter the food supply or the environment, they can pose significant public health risks, as antibiotic-resistant bacteria can potentially infect humans. In response to concerns about antibiotic resistance, regulatory authorities may impose restrictions on the use of certain antibiotics in cattle farming. This can impact treatment protocols and require cattle producers to adopt alternative healthcare strategies. Consumers are increasingly concerned about the use of antibiotics in animal agriculture. They may seek beef and dairy products labeled as antibiotic-free or produced using responsible antibiotic use practices. Meeting these consumer preferences may require changes in cattle health management. Some countries have specific regulations regarding antibiotic use in cattle farming, and compliance with these regulations is necessary for international trade. Antibiotic resistance concerns can affect market access and trade negotiations. Concerns about antibiotic resistance have led to a shift in the cattle health market towards alternative healthcare strategies. This includes the development and adoption of vaccines, probiotics, prebiotics, and other non-antibiotic-based solutions for disease prevention and management. Veterinarians play a key role in managing antibiotic use in cattle health. There may be increased scrutiny and oversight by veterinarians to ensure responsible antibiotic use and compliance with regulatory guidelines.

Key Market Trends

Traceability and Food Safety

Consumers are increasingly concerned about the safety and quality of the food they consume, including beef and dairy products. Traceability systems and food safety measures provide transparency and assurance to consumers, enhancing their confidence in these products. Many consumers seek products labeled with information about the origin of the meat or dairy, including details about where and how the cattle were raised. This labeling provides a level of traceability and helps consumers make informed choices. Regulatory agencies in many countries have implemented stringent requirements for traceability and food safety in cattle farming. Compliance with these regulations is essential for cattle producers to operate legally and access markets. In the event of a food safety issue or product recall, traceability systems allow for rapid identification of affected products and the source of contamination. This helps minimize the scope and impact of recalls. Traceability systems can aid in disease surveillance and response efforts. In the event of a disease outbreak, authorities can trace the movements of cattle to identify potential sources of infection and implement control measures more effectively. Traceability systems provide transparency throughout the entire cattle supply chain, from farm to fork. This transparency helps identify and address potential bottlenecks or inefficiencies in the supply chain. Ensuring the health and well-being of cattle through robust health management practices is a fundamental aspect of food safety and quality assurance. Healthy cattle are less likely to carry zoonotic diseases or pathogens that can contaminate meat and dairy products. Genetic traceability is becoming more prevalent, allowing consumers to trace the genetic heritage of the cattle. This can be used to verify breed authenticity and ensure product quality. Some traceability systems use blockchain technology to create immutable records of cattle-related data. Blockchain ensures data integrity and security, making it difficult for information to be tampered with or altered.

Segmental Insights

Therapeutics Insights

In 2022, the Global Cattle Health Market was dominated by Vaccine segment in the forecast period and is predicted to continue expanding over the coming years. Vaccines are a cornerstone of preventive healthcare in cattle farming. They are crucial for protecting cattle against a wide range of diseases, including viral and bacterial infections. Vaccination helps reduce the incidence and severity of diseases, lowering mortality rates and production losses. Cattle are susceptible to various diseases, including bovine respiratory disease, brucellosis, bovine viral diarrhoea, and foot-and-mouth disease, among others. The vaccine segment offers a broad range of vaccines designed to prevent or control these diseases, making it a critical component of cattle health management. In some regions, vaccination plays a pivotal role in disease eradication programs. For example, vaccination is used to control and eventually eliminate diseases like foot-and-mouth disease in specific geographic areas.

Diagnostics Insights

In 2022, the Global Cattle Health Market dominated by Immunodiagnostic Test segment and is predicted to continue expanding over the coming years. Immunodiagnostic tests, such as enzyme-linked immunosorbent assays (ELISAs) and rapid diagnostic tests, are highly effective in detecting various diseases in cattle. These tests can detect specific antibodies or antigens associated with diseases, allowing for early and accurate diagnosis. Cattle producers and veterinarians often use immunodiagnostic tests as part of their preventive healthcare programs. Regular testing helps identify diseases in their early stages, enabling prompt treatment and preventing disease outbreaks within herds. Large cattle operations, including feedlots and dairy farms, rely on immunodiagnostic tests to manage the health of their herds effectively. Regular testing helps monitor the overall health status of the herd and identify any potential issues.

Regional Insights

The North America region dominates the Global Cattle Health Market in 2022. North America, particularly the United States and Canada, has a substantial cattle population. The United States is one of the world's largest beef-producing countries. This large cattle population creates a substantial market for cattle health products and services. North America has a well-established and advanced veterinary care system. This includes many skilled veterinarians, modern veterinary clinics, and research institutions focused on cattle health. These resources contribute to the development and adoption of innovative cattle health solutions. North America has been at the forefront of adopting advanced technologies in agriculture, including cattle farming. The region has embraced digital health monitoring, data analytics, and precision livestock farming, which enhance cattle health management.

Key Market Players

• Qiagen LLC

• Boehringer Ingelheim

• Thermo Fisher Scientific

• Elanco Animal Health

• Idexx Laboratories

• ID Vet

• Kyoritsuseiyaku Corporation

• Merck & Co Inc.

• Norbrook laboratories

• Zoetis Inc.

Report Scope:

In this report, the Global Cattle health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cattle Health Market, By Therapeutics:

• Vaccine
• Parasiticide
• Anti-infective
• Medical Feed Additive
• Other Therapeutics

Cattle Health Market, By Diagnostics:

• Immunodiagnostic Test
• Molecular Diagnostics
• Diagnostic Imaging
• Clinical Chemistry
• Other Diagnostics

Global Cattle Health Market, By region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Cattle Health Market.

Available Customizations:

• Global Cattle Health Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Cattle Health Market

5. Voice of Customer

6. Global Cattle Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapeutics (Vaccine, Parasiticide, Anti-infective, Medical Feed Additive, and Other Therapeutics)
  • 6.2.2. By Diagnostics (Immunodiagnostic Test, Molecular Diagnostics, Diagnostic Imaging, Clinical Chemistry, and Other Diagnostics)
  • 6.2.3. By Region
  • 6.2.4. By Company (2022)
• 6.3. Market Map

7. Asia Pacific Cattle Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapeutics
  • 7.2.2. By Diagnostics
  • 7.2.3. By Country
• 7.3. Asia Pacific: Country Analysis
  • 7.3.1. China Cattle Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapeutics
      • 7.3.1.2.2. By Diagnostics
  • 7.3.2. India Cattle Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapeutics
      • 7.3.2.2.2. By Diagnostics
  • 7.3.3. Australia Cattle Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapeutics
      • 7.3.3.2.2. By Diagnostics
  • 7.3.4. Japan Cattle Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapeutics
      • 7.3.4.2.2. By Diagnostics
  • 7.3.5. South Korea Cattle health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapeutics
      • 7.3.5.2.2. By Diagnostics

8. Europe Cattle Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapeutics
  • 8.2.2. By Diagnostics
  • 8.2.3. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Cattle health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapeutics
      • 8.3.1.2.2. By Diagnostics
  • 8.3.2. Germany Cattle Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapeutics
      • 8.3.2.2.2. By Diagnostics
  • 8.3.3. Spain Cattle Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapeutics
      • 8.3.3.2.2. By Diagnostics
  • 8.3.4. Italy Cattle Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapeutics
      • 8.3.4.2.2. By Diagnostics
  • 8.3.5. United Kingdom Cattle Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapeutics
      • 8.3.5.2.2. By Diagnostics

9. North America Cattle Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapeutics
  • 9.2.2. By Diagnostics
  • 9.2.3. By Country
• 9.3. North America: Country Analysis
  • 9.3.1. United States Cattle Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapeutics
      • 9.3.1.2.2. By Diagnostics
  • 9.3.2. Mexico Cattle Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapeutics
      • 9.3.2.2.2. By Diagnostics
  • 9.3.3. Canada Cattle Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapeutics
      • 9.3.3.2.2. By Diagnostics

10. South America Cattle health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapeutics
  • 10.2.2. By Diagnostics
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cattle Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapeutics
      • 10.3.1.2.2. By Diagnostics
  • 10.3.2. Argentina Cattle Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapeutics
      • 10.3.2.2.2. By Diagnostics
  • 10.3.3. Colombia Cattle Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapeutics
      • 10.3.3.2.2. By Diagnostics

11. Middle East and Africa Cattle Health Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Therapeutics
  • 11.2.2. By Diagnostics
  • 11.2.3. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Cattle health Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Therapeutics
      • 11.3.1.2.2. By Diagnostics
  • 11.3.2. Saudi Arabia Cattle Health Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Therapeutics
      • 11.3.2.2.2. By Diagnostics
  • 11.3.3. UAE Cattle Health Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Therapeutics
      • 11.3.3.2.2. By Diagnostics

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

• 13.1. Recent Developments
• 13.2. Product Launches
• 13.3. Mergers & Acquisitions

14. Global Cattle Health Market: SWOT Analysis

15. Porter's Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Product

16. PESTLE Analysis

17. Competitive Landscape

• 17.1. Business Overview
• 17.2. Company Snapshot
• 17.3. Products & Services
• 17.4. Financials (In case of listed companies)
• 17.5. Recent Developments
• 17.6. SWOT Analysis
  • 17.6.1. Qiagen LLC
  • 17.6.2. Boehringer Ingelheim
  • 17.6.3. Thermo Fisher Scientific
  • 17.6.4. Elanco Animal Health
  • 17.6.5. Idexx Laboratories
  • 17.6.6. ID Vet
  • 17.6.7. Kyoritsuseiyaku Corporation
  • 17.6.8. Merck & Co Inc.
  • 17.6.9. Norbrook laboratories
  • 17.6.10. Zoetis Inc.

18. Strategic Recommendations

19. About Us & Disclaimer